In another signal of the appetite among investors for companies applying artificial intelligence to drug discovery, Pathos AI has gathered an impressive $365 million in fourth-round financing as it ...

A British marketing agency ranked among Europe's fastest-growing businesses is planning to float on the London Stock Exchange later this month, The Mail on Sunday understands. Pathos Communications, ...

2K Games has poached Apex Legends producer Ben Brinkman from Respawn to head up the team at 31st Union, which is developing 2K's upcoming third-person roguelike extraction-shooter, Project Ethos. On ...

GameSpot may get a commission from retail offers. 2K Games hasn't said much about its free-to-play third-person shooter currently in the works under the working title Project Ethos, but the game is ...

Ethos Technologies Inc. (LIFE) has filed to raise $100 million in an IPO of its Class A common stock, according to SEC S-1 registration information. LIFE provides a life insurance marketplace for ...

Defense Secretary Pete Hegseth is convening hundreds of high-ranking officers on short notice for a meeting in Virginia on Tuesday to give a speech on his views of the “warrior ethos” amid his ...

Sept 26 (Reuters) - Ethos Technologies recorded a 55% jump in revenue in the first half of 2025, according to its U.S. initial public offering paperwork filed on Friday, as the insurance IPO market ...

Defense Secretary Pete Hegseth has ordered hundreds of generals to Virginia next week to discuss grooming, standards and his “warrior ethos” vision — an unusual move that has sparked confusion among ...

Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised $365 million in a late-stage funding. The company didn’t disclose the ...

Pathos AI has secured $365 million in a series D raise as the artificial-intelligence-powered biotech looks to fund trials of solid tumor drugs sourced from Novo Nordisk and Prelude Therapeutics. The ...

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Pathos AI, a leading AI-enabled biotech company focused on transforming drug development in oncology, today announced the appointment of Iker Huerga as Chief ...